These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 25385826)

  • 1. Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors.
    Reeve E; Andrews JM; Wiese MD; Hendrix I; Roberts MS; Shakib S
    Ann Pharmacother; 2015 Jan; 49(1):29-38. PubMed ID: 25385826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
    McIntyre C; McQuillan R; Bell C; Battistella M
    Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process.
    Reeve E; Shakib S; Hendrix I; Roberts MS; Wiese MD
    Br J Clin Pharmacol; 2014 Oct; 78(4):738-47. PubMed ID: 24661192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of a multi-faceted intervention to deprescribe proton pump inhibitors in primary care: protocol for a population-based, pragmatic, cluster-randomized controlled trial.
    Nguyen-Soenen J; Rat C; Gaultier A; Schirr-Bonnans S; Tessier P; Fournier JP
    BMC Health Serv Res; 2022 Feb; 22(1):219. PubMed ID: 35177042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a Proton Pump Inhibitor Deprescribing Guideline on Drug Usage and Costs in Long-Term Care.
    Thompson W; Hogel M; Li Y; Thavorn K; O'Donnell D; McCarthy L; Dolovich L; Black C; Farrell B
    J Am Med Dir Assoc; 2016 Jul; 17(7):673.e1-4. PubMed ID: 27289201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deprescribing in a family health team: a study of chronic proton pump inhibitor use.
    Walsh K; Kwan D; Marr P; Papoushek C; Lyon WK
    J Prim Health Care; 2016 Jun; 8(2):164-71. PubMed ID: 27477559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful deprescribing of proton pump inhibitors with a patient-centered process: the DESPIBP Project.
    Calvo LLJ; García Cámara P; Llorente Barrio M; Sierra Gabarda O; Monzón Baez R; Arbonés Mainar JM; Alcedo González J; Bernal Monterde V
    Eur J Clin Pharmacol; 2021 Dec; 77(12):1927-1933. PubMed ID: 34269841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deprescribing medications in older people: a narrative review.
    Salahudeen MS
    Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.
    Moriarty F; Bennett K; Cahir C; Fahey T
    J Am Geriatr Soc; 2016 Dec; 64(12):e291-e296. PubMed ID: 27996115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Deprescribing in Older Adults with Chronic Kidney Disease.
    Triantafylidis LK; Hawley CE; Perry LP; Paik JM
    Drugs Aging; 2018 Nov; 35(11):973-984. PubMed ID: 30284120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Interventions to Deprescribe Inappropriate Proton Pump Inhibitors in Older Adults.
    Wilsdon TD; Hendrix I; Thynne TR; Mangoni AA
    Drugs Aging; 2017 Apr; 34(4):265-287. PubMed ID: 28220380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and Provider Perspectives on Deprescribing Proton Pump Inhibitors.
    Ikeji C; Williams A; Hennawi G; Brandt NJ
    J Gerontol Nurs; 2019 Oct; 45(10):9-17. PubMed ID: 31560071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study.
    Aubert CE; Blum MR; Gastens V; Dalleur O; Vaillant F; Jennings E; Aujesky D; Thompson W; Kool T; Kramers C; Knol W; O'Mahony D; Rodondi N
    CMAJ Open; 2023; 11(1):E170-E178. PubMed ID: 36854455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy.
    Galazzi A; Lusignani M; Chiarelli MT; Mannucci PM; Franchi C; Tettamanti M; Reeve E; Nobili A
    Int J Clin Pharm; 2016 Apr; 38(2):454-61. PubMed ID: 26951120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Implementation of a Pharmacist-Led Proton Pump Inhibitor Deprescribing Algorithm in a Geriatric Ambulatory Office.
    Leszcynski L; Bente J
    Sr Care Pharm; 2023 Mar; 38(3):105-112. PubMed ID: 36803698
    [No Abstract]   [Full Text] [Related]  

  • 16. Inappropriate proton-pump inhibitor prescribing in primary care - an observational study with quality circles.
    Vidonscky Lüthold R; Henz NC; Fuhrer C; Häner A; Schenk M; Jungo KT; Streit S
    Swiss Med Wkly; 2023 Sep; 153():40119. PubMed ID: 37769322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing to Reduce Medication Use: Will This Help Your Patient?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2016 Nov; 54(11):21-24. PubMed ID: 27805712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. We have had a gutful: The need for deprescribing proton pump inhibitors.
    Naunton M; Peterson GM; Deeks LS; Young H; Kosari S
    J Clin Pharm Ther; 2018 Feb; 43(1):65-72. PubMed ID: 28895169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The benefits and harms of deprescribing.
    Reeve E; Shakib S; Hendrix I; Roberts MS; Wiese MD
    Med J Aust; 2014 Oct; 201(7):386-9. PubMed ID: 25296058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct-to-consumer strategies to promote deprescribing in primary care: a pilot study.
    Linsky AM; Kressin NR; Stolzmann K; Pendergast J; Rosen AK; Bokhour BG; Simon SR
    BMC Prim Care; 2022 Mar; 23(1):53. PubMed ID: 35317734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.